Contractile action of galanin analogues on rat isolated gastric fundus strips is modified by tachyphylaxis to substance P

Pharmacological Research

Volumn 33, Issue 6, 1996, Pages 361-365

  Korolkiewicz, R ^a   Sliwinski W ^a   Rekowski, P ^b   Halama, A ^b   Mucha, P ^b   Szczurowicz, A ^a   Guzowski, P ^a   Korolkiewicz, K Z ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Galanin; Rats; Smooth muscle; Substance P; Tachyphylaxis

Indexed keywords

GALANIN; GALANIN DERIVATIVE; GALANIN RECEPTOR; SUBSTANCE P;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STOMACH FUNDUS; STOMACH MUSCLE; TACHYPHYLAXIS;

EID: 0030175127     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0050     Document Type: Article

References (24)

1. 1. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V. Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-8.
2. 2. Bartfai T. Galanin. A neuropeptide with important central nervous system action. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press Ltd, 1995: 563-71.
3. 3. Rökaeus A. Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci 1987; 10: 158-64.
4. 4. Melander T, Hökfelt T, Rökaeus A, Fahrenkrug J, Tatemoto K, Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tiss Res 1985; 239: 253-70.
5. 5. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 1989; 97: 260-4.
6. 6. Ottlecz A, Samson WK, McCann SM. Galanin: evidence for a hypothalamic site of action to release growth hormone. Peptides 1986; 7: 51-5.
7. 7. Koshiyama H, Kato Y, Inoue T, Murakami Y, Ishikawa Y, Yanaihara N, Imura H. Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide. Neurosci Lett 1987; 75: 49-54.
8. 8. McDonald TJ, Dupre J, Tatemoto K, Greenberg GR, Radziuk J, Mutt V. Galanin inhibits insulin secretion and induces hyperglycaemia in dogs. Diabetes 1985; 34: 192-6.
9. 9. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neural 1988; 273: 543-57.
10. 10. Rossowski WJ, Rossowski TM, Zacharia S, Ertan A, Coy DH. Galanin binding sites in rat gastric and jejunal smooth muscle membrane preparations. Peptides 1990; 11: 333-8.
11. 11. Katsoulis S, Schmidt WE, Schwörer H, Creutzfeldt W. Effects of galanin, its analogues and fragments on rat isolated fundus strips. Br J Pharmacol 1990; 101: 297-300.
12. 12. Bartfai T, Bedecs K, Land T, Langel U, Bertorelli R, Girotti P, Consolo S, Xu X, Wiesenfeld-Hallin Z, Nilsson S, Pieribone VA, Hökfelt T. M-15: High-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci USA 1991; 88: 10961-5.
13. 13. Lindskog S, Ahren B, Land T, Langel U, Bartfai T. The novel high-affinity antagonist, galantide blocks the galanin-mediated inhibition of glucose induced insulin secretion. Eur J Pharm 1992; 210: 183-8.
14. 14. Gu Z-FA, Rossowski WJ, Coy DH, Pradhan TK, Jensen RT. Chimeric galanin analogues that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther 1993; 266: 912-8.
15. 15. Rolka K. Tachykinins - structure and biological properties. Wiad Chem 1990; 44: 803-18 (in Polish).
16. 16. Śliwiński W, Rekowski P, Halama A, Korolkiewicz R. Characteristics of interaction between galanin and its analogues with galanin receptor in the rat stomach fundus. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 352 Suppl: R12-A47.
17. 17. Vane JR. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol 1957; 12: 344-9.
18. 18. Holzer-Petsche U, Seitz H, Lembeck F. Effect of capsaicin on gastric corpus smooth muscle of the rat in vitro. Eur J Pharmacol 1989; 162: 29-36.
19. 19. Rekowski P, Halama A, Mucha P, Kupryszewski G, Poćwiardowska E, Korolkiewicz KZ. Galanin and its analogues: synthesis and studies of their agonist activity on smooth muscles. Pol J Chem 1993; 67: 233-44.
20. 20. Rolka K, Kupryszewski G, Janas P, Myszor J, Herman ZS. Synthesis and biological activity in GPI test of scyliorhinin I and its analogues modified in position 8 by Leu, Sar and Pro residues. Collect Czech Chem Commun 1991; 56: 1957-62.
21. 21. Conlon JM, Deacon CF, O'Toole L, Thim L. Scyliorhinin I and II: two novel tachykinins from dogfish gut. FEBS Lett 1986; 200: 111-6.
22. 22. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs, 2nd edition. New York: Springer, 1986.
23. 23. Barlow RB. In: Biodata handling with microcomputers. Programs written in BASIC for handling biological, biochemical, pharmacological and physicochemical results with a commentary on the calculations involved. Amsterdam: Elsevier Science, 1983.
24. 24. Tallarida RJ, Raffa RB, McGonigle P. Radioligand binding. Direct binding. Hill plot. In: Tallarida RJ, Raffa RB, McGonigle P, eds. Principles in general pharmacology. New York: Springer, 1988: Chapter 9: 211-2.